FREDERICK, Colo.--(BUSINESS WIRE)--Sparton Corporation (NYSE: SPA), a supplier of complex and reliable electronic and electro-mechanical products, sub-assemblies and related services to the highly regulated Medical, Defense & Security, and Aerospace markets, announces an initial contract manufacturing award from Talyst, Inc. located in Bellevue, WA.
Talyst is a leading provider of pharmacy automation, medication dispensing and medication packaging solutions. Committed to the precise delivery of medications for patients in long-term care facilities and acute care Hospitals, Talyst engineers the safer pharmacy.
“Our decision to partner with Sparton was driven by their quality and process capabilities demonstrated by their work on our award winning AutoCool product,” said Carla Corkern, Chief Executive Officer at Talyst. “Talyst truly feels that Sparton plays a significant role in supporting our market leadership and we look forward to our collective success.”
Sparton will provide a full system build at its Fredrick, Colorado operation utilizing its internal circuit card assembly capability, contemporary quality tools, and collaborative manufacturing process.
“Partnering and collaborating with our customers to ensure mutual success is one of our corporate values,” commented Cary Wood, President& CEO of Sparton Corporation. “This contract win is also a leading indicator that our new business development efforts are beginning to take hold and we are excited with the opportunity that Talyst has given us to be their extended manufacturing arm.”
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 111th year, is empowering its customers vision as a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, and field service to technology-driven companies in the medical device, defense & security systems, and electronic manufacturing services markets. Headquartered in Schaumburg, Ill., Sparton currently has four manufacturing locations worldwide. The Company's website may be accessed at www.sparton.com.
Talyst is engineering the safer pharmacy. The company was founded in 2002 to provide automated medication-management systems to acute-care hospital pharmacies. The following year Talyst launched AutoPharm®, the innovative software platform designed to drive a complete suite of medication storage, packaging, refrigeration and barcoding hardware.
As of 2010, Talyst has installed automated systems in more than 500 acute-care hospitals, integrated healthcare companies, long-term care facilities and correctional institutions. Talyst is dedicated to delivering world-class software and proven hardware components to enhance efficiency, provide greater inventory control and improve patient safety in all care environments. The company's website may be accessed at www.talyst.com.
Safe Harbor and Fair Disclosure Statement
Certain statements described in this press release are forward-looking statements within the scope of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements may be identified by the words “believe,” “expect,” “anticipate,” “project,” “plan,” “estimate,” “will” or “intend” and similar words or expressions. These forward-looking statements reflect Sparton’s current views with respect to future events and are based on currently available financial, economic and competitive data and its current business plans. Actual results could vary materially depending on risks and uncertainties that may affect Sparton’s operations, markets, prices and other factors. Important factors that could cause actual results to differ materially from those forward-looking statements include, but are not limited to, Sparton’s financial performance and the implementations and results of its ongoing strategic initiatives. For a more detailed discussion of these and other risk factors, see Part I, Item 1A, Risk Factors and Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Sparton’s Form 10-K for the year ended June 30, 2009, and its other filings with the Securities and Exchange Commission. Sparton undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.